XML Securities’s Antares Pharma, Inc. ATRS Stock Holding History

XML Securities’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-20,000	Closed	-$40K	–	85
2017 Q4	$40K	Buy	+20,000	New	+$43.5K	0.05%	75

Other funds holding ATRS

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XML Securities's ATRS Position: Q1 2018 in Review

XML Securities sold out of Antares Pharma, Inc. (ATRS) in Q1 2018, closing a stake of 20,000 shares — an estimated $40K sold.

XML Securities first reported a position in ATRS in Q4 2017 and held it in 1 quarter. The position peaked at $40K in Q4 2017. 102 funds tracked by Wall St. Rank hold ATRS as of Q1 2018.

XML Securities reported no remaining Antares Pharma, Inc. position as of Q1 2018 after selling out during the quarter.
XML Securities sold 20,000 Antares Pharma, Inc. shares in Q1 2018, an estimated $40K.
XML Securities first reported a position in Antares Pharma, Inc. in Q4 2017 and held it in 1 quarter.
XML Securities's Antares Pharma, Inc. position peaked at $40K in Q4 2017.
102 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2018.

Based on XML Securities's 13F filing for Q1 2018, filed 17 May 2018.